Association of Component Strategies of the Target Stroke Phase 3 Nationwide Quality Improvement Program With Accelerated Door-to-Puncture and Door-In-Door-Out Times for Ischemic Stroke Endovascular Thrombectomy in the United States

By afschroeder • October 20, 2025

Mac Grory B, Asif KS, Xu H, Alhanti B, Lusk J, Hasan D, Park S, Boehme AK, Zachrison KS, Goyal M, Southerland AM, Jadhav A, Ortega Gutierrez S, Hassan A, Fargen K, Sheth KN, Jauch EC, Xian Y, Peterson ED, Smith EE, Messe SR, Schwamm LH, Panagos P, Wira C, Saver JL, Fonarow GC. Association of Component Strategies of the Target Stroke Phase 3 Nationwide Quality Improvement Program With Accelerated Door-to-Puncture and Door-In-Door-Out Times for Ischemic Stroke Endovascular Thrombectomy in the United States. Circ Cardiovasc Qual Outcomes. 2025 Oct 20:e012456. doi: 10.1161/CIRCOUTCOMES.125.012456. Epub ahead of print. PMID: 41111412.

Tags: Cardiology/Epi, ischemic stroke, Publications, quality improvement, stroke, thrombolytic therapy, Treatment outcome

Effect of colchicine on progression of known coronary atherosclerosis in patients with stable coronary artery disease: EKSTROM randomized placebo controlled trial

Budoff MJ, Bhandari M, Iskander B, Ghanem AK, Kinninger A, Stark J, Garikapati V, Chilukuri S, Hankil V, Krishnan S, Punnanithinont N, Ichikawa K, Kambalapalli[...]

Potent P2Y12 Inhibitor Monotherapy Versus Dual Antiplatelet Therapy After Percutaneous Coronary Intervention for Acute Coronary Syndromes: A Systematic Review and Meta-Analysis

Ibrahim M, Tariq S, Afridi MK, Zafar A, Khamisani FA, Aminpoor H, Arfin SMW, Fonarow GC, Greene SJ, Musani MH, Waqas SA. Potent P2Y12 Inhibitor[...]

Hemodynamics-driven magnetoelastic vascular grafts for stenosis diagnosis

Chen G, Chung T, Liu Z, Li YR, Scott K, Zhao X, Carol J, Park S, Zhou Y, Kim WJ, Ge X, Colby GP, Li[...]